Anang Mufti Sumarsono
Department Of Surgery, Faculty Of Medicine, Universitas Hang Tuah, Dr. Ramelan Naval Hospital, Surabaya

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Profil Pasien Kanker Payudara Yang Menjalani Kemoterapi Di Rspal Dr. Ramelan Surabaya Periode Januari – Desember 2021 SEKAR KURNIA CAHYA; ANANG MUFTI SUMARSONO; PRAWESTY DIAH UTAMI
Hang Tuah Medical Journal Vol 22 No 1 (2024): Hang Tuah Medical Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/htmj.v22i1.416

Abstract

Background : Breast cancer is the most frequent cancer that occurs in Indonesia and becomes the main cause of mortality. Progression of breast cancer is affected by various factors, such as age, occupational status, menopause, estrogens, and lifestyle with high-fat dietary and alcohol consumption. Breast cancer progressivity may be stopped by surgery, chemotherapy, radiation, and hormonal therapy. Chemotherapy is an anticancer treatment management with the aim of killing cancer cells in the body and preventing recurrence and metastasis by administering cytotoxic agents. Chemotherapy may be performed previous to surgery (neoadjuvant) to achieve the decreased size of the tumor and facilitate the resection surgery. It may be performed as well after the surgery (adjuvant) to destroy any residual tumor cells. This study aimed to describe the profile of breast cancer patients who underwent chemotherapy from January to December 2021 at RSPAL Dr. Ramelan Surabaya. Methods: This study was descriptive with a retrospective design. Data collected from secondary sources of medical records patients with breast cancer in RSPAL Dr. Ramelan Surabaya from January to December 2021. Results: From the 79 samples, the most frequent age group in this study was a group of pre-elderly (45-59 years old). Most breast cancer patients are housewife. Breast cancer was commonly found in stage III. The most frequent chemotherapy management implemented for the breast cancer patient was adjuvant chemotherapy. Conclusion: women aged 45-59 years, not working, stage III, receiving adjuvant chemotherapy. Keywords : breast cancer, age, occupation, staging, chemotherapy
Benefit of Noni Fruit (Morinda citrifolia) Extract in Reducing SGOT and SGPT Levels in Male White Rats (Rattus norvegicus) Induced by Doxorubicin Ainaka Fatihi Gusmardi; Diah Purwaningsari; Anang Mufti Sumarsono
Majalah Biomorfologi Vol. 36 No. 1 (2026): MAJALAH BIOMORFOLOGI
Publisher : Universitas Airlangga, Surabaya, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/mbiom.v36i1.2026.66-74

Abstract

Background: Drug-related hepatic injury, recognized as drug-induced liver injury (DILI), constitutes a significant global cause of acute hepatic damage, often resulting from exposure to conventional medications or traditional herbal remedies. Morinda citrifolia, a tropical fruit rich in antioxidants, offers potential hepatoprotection against oxidative stress induced by agents such as doxorubicin. Oxidative stress plays a central role in doxorubicin-induced hepatocellular damage, highlighting the need for adjunctive protective strategies. Objective:Ā  To evaluate whether Morinda citrifolia fruit extract could exert a hepatoprotective effect in male Wistar rats (Rattus norvegicus) subjected to doxorubicin-induced liver injury by measuring serum SGOT and SGPT levels. Materials and Methods: In this controlled post-intervention laboratory experiment, the authors classified 32 male Wistar rats into four groups (n = 8 per group): Cāˆ’ (standard diet only); C+ (intraperitoneal doxorubicin 20 mg/kg BW with a standard diet); CT1 (intraperitoneal doxorubicin 20 mg/kg BW followed by oral Morinda citrifolia extract at 500 mg/kg BW); and CT2 (intraperitoneal doxorubicin 20 mg/kg BW followed by oral Morinda citrifolia extract at 1000 mg/kg BW). The rats were sacrificed after 6 days and blood analysis was performed. Results: Blood analysis revealed significant different SGOT and SGPT levels between groups. Mean SGOT levels decreased significantly in CT1 versus C+ (P = 0.042) and CT2 versus C+ (P = 0.008). Mean SGPT levels declined in CT1 compared with C+ (P = 0.003) and CT2 compared with C+ (P = 0.002). Conclusion: Morinda citrifolia fruit extract at 500 and 1000 mg/kg BW effectively lowers doxorubicin-elevated SGOT and SGPT levels, indicating hepatoprotective potential.
Profil Pasien Kanker Payudara Yang Menjalani Kemoterapi Di Rspal Dr. Ramelan Surabaya Periode Januari – Desember 2021 SEKAR KURNIA CAHYA; ANANG MUFTI SUMARSONO; PRAWESTY DIAH UTAMI
Hang Tuah Medical Journal Vol 22 No 1 (2024): Hang Tuah Medical Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/htmj.v22i1.416

Abstract

Background : Breast cancer is the most frequent cancer that occurs in Indonesia and becomes the main cause of mortality. Progression of breast cancer is affected by various factors, such as age, occupational status, menopause, estrogens, and lifestyle with high-fat dietary and alcohol consumption. Breast cancer progressivity may be stopped by surgery, chemotherapy, radiation, and hormonal therapy. Chemotherapy is an anticancer treatment management with the aim of killing cancer cells in the body and preventing recurrence and metastasis by administering cytotoxic agents. Chemotherapy may be performed previous to surgery (neoadjuvant) to achieve the decreased size of the tumor and facilitate the resection surgery. It may be performed as well after the surgery (adjuvant) to destroy any residual tumor cells. This study aimed to describe the profile of breast cancer patients who underwent chemotherapy from January to December 2021 at RSPAL Dr. Ramelan Surabaya. Methods: This study was descriptive with a retrospective design. Data collected from secondary sources of medical records patients with breast cancer in RSPAL Dr. Ramelan Surabaya from January to December 2021. Results: From the 79 samples, the most frequent age group in this study was a group of pre-elderly (45-59 years old). Most breast cancer patients are housewife. Breast cancer was commonly found in stage III. The most frequent chemotherapy management implemented for the breast cancer patient was adjuvant chemotherapy. Conclusion: women aged 45-59 years, not working, stage III, receiving adjuvant chemotherapy. Keywords : breast cancer, age, occupation, staging, chemotherapy